Antidepressant may prevent severe COVID-19 (IMAGE)
Caption
A discovery by Alban Gaultier, PhD, of the University of Virginia School of Medicine, prompted a clinical trial of the antidepressant fluvoxamine for the treatment of COVID-19.
Credit
Dan Addison | UVA Communications
Usage Restrictions
May be used to accompany news coverage of the COVID-19 trial results. All other uses require express written permission from UVA Health.
License
Licensed content